The cost of taking bosentan tablets for one year
Bosentan (Bosentan), this drug for pulmonary arterial hypertension, exerts a therapeutic effect by antagonizing endothelin A receptors and endothelin B receptors. It can dilate pulmonary arteries and reduce vascular resistance, thereby effectively reducing pulmonary arterial hypertension. As for how long it takes for patients to take bosentan to see obvious antihypertensive effects, this needs to be analyzed based on the patient's specific condition and physical condition.

Bosentan is available by prescription only, and treatment should only be initiated and monitored by a physician experienced in treating PAH or systemic sclerosis. It is available as film-coated tablets (62.5 mg; 125 mg) and dispersible tablets (32 mg). BosentanTake it morning and evening. The starting dose for adults should be 62.5 mg twice daily for four weeks, then increasing to the usual dose of 125 mg twice daily. The recommended starting and maintenance dose for children 1 year and older with PAH is 2 mg per kilogram of body weight twice daily.
The cost of a patient's treatment with bosentan will change based on the patient's dosage and the price reimbursed by medical insurance. The dosage of different patients may not be the same. As for the specific cost of using bosentan tablets for one year, it is recommended that patients understand the relevant prices and calculate the one-year cost of the medication.
Bosentan tablets have been launched in the domestic market and have been included in the scope of medical insurance reimbursement. The specification of this drug is 56 tablets of 125mg, and the price after medical insurance is about 3,000 yuan. In addition, we also learned that Indian cipla pharmaceuticals has also launched a generic version of bosentan overseas, with a specification of 125ng and 20 tablets, and a price of about 400 yuan. The generic version of bosentan launched overseas is also well received by patients, and patients can choose according to their own needs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)